Stay updated on CARDINAL Trial: Bardoxolone Methyl in Alport Syndrome
Sign up to get notified when there's something new on the CARDINAL Trial: Bardoxolone Methyl in Alport Syndrome page.

Latest updates to the CARDINAL Trial: Bardoxolone Methyl in Alport Syndrome page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedUpdated the page’s software/footer revision indicator from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check21 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 from the study record history.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check49 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 from the Record History section.SummaryDifference0.1%

- Check57 days agoChange DetectedA new revision entry v3.4.3 was added and the previous revision v3.4.2 removed.SummaryDifference0.1%

- Check85 days agoChange DetectedA new revision entry for v3.4.2 was added and the v3.4.1 entry removed in the history; no other visible changes to the page content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check92 days agoChange DetectedA new revision entry v3.4.1 was added to the history and the previous v3.4.0 entry was removed. This change affects only the revision log and does not alter trial data or core content.SummaryDifference0.1%

Stay in the know with updates to CARDINAL Trial: Bardoxolone Methyl in Alport Syndrome
Enter your email address, and we'll notify you when there's something new on the CARDINAL Trial: Bardoxolone Methyl in Alport Syndrome page.